We expect Novo to gain $75 billion of a more than $200 billion global GLP-1 market in diabetes and obesity by 2031, ahead of semaglutide's 2032 patent expiration, with Lilly standing as the firm's key ...

Haemophilia A is a rare blood disorder caused by missing or defective factor VIII (FVIII), a clotting protein, meaning a patient’s blood struggles to clot. Mim8 is a bispecific monoclonal ...

Antibody therapy Mim8 was found to be safe and effective for controlling bleeds in children with hemophilia A in a Phase 3 ...

The affinity for scanning a sonnet or identifying structure in a well-composed English lyric is similar to wanting to develop models that make genomic or protein sequences more interpretable and ...

Vimentin is a type III intermediate filament (IF) protein normally expressed in cells that develop into connective tissue, blood vessels, and lymphatic tissue (mesenchymal cells). Despite being widely ...

Novo Nordisk's anti-TFPI antibody concizumab has been backed for approval in the EU as a once-daily drug to prevent bleeding episodes in people with haemophilia. The recommendation by the EMA's ...

Haemophilia A is a rare blood disorder caused by missing or defective factor VIII (FVIII), a clotting protein, meaning a patient’s blood struggles to clot. Mim8 is a bispecific monoclonal antibody ...

Strep throat, something we've all had at some point in our lives, is caused by the bacteria Streptococcus pyogenes. Infection ...

Pfizer's Hympavzi has become the first once-weekly subcutaneous treatment for people living with severe haemophilia B in the EU that can be delivered via an autoinjector device at home.

But what are some easy prep-ahead options packed with muscle-building protein? Dietitians share 20 of their favorite meal prep ideas that are delicious, satiating and easy to make. A ½ cup of ...